Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Presentations

Lipocine 1144 Presentation-LiFT Topline 36 Week Results

Download the Presentation

LPCN 1144 LiFT 12 Week Study Results

Download the Presentation

LPCN 1148 Presentation

Download the Presentation

Corporate Presentation

Download the Presentation

LPCN 1144 Presentation

Download the Presentation